Genomics-driven drug design for precision oncology
Over the past couple of decades, the exponential progress of sequencing technologies has allowed an increasing number of cancer patients to benefit from precision oncology.
However, the aggregation, analysis, and visualization of the massive amounts of genomic data remain a major challenge for precision oncology expansion.
The Epigene Labs technology platform enables cancer drug hunters to seamlessly leverage advanced artificial intelligence in transforming genomic data into actionable insights for designing precision oncology approaches.
With R&D in Paris and business development in Boston, Epigene Labs operates in the setting of value-based partnerships with world leading cancer centers and high-profile biotechs.
PRECISION ONCOLOGY CYCLE
We are humble. We are bold.
Akpéli Nordor, PharmD, PhD
Co-founder & President
Arthur de Garidel, JD, MSc
Julien Haziza, PharmD, MSc
They trust us
Harvard Innovation Labs
GET IN TOUCH
Interested in partnering or working with us? Drop us a line!
Akpéli is a pharmacist-scientist leveraging genomics and data sciences to fight cancer.
As a co-founder of Epigene Labs based in Paris, he primarily focuses on building and managing the company’s R&D team.
Arthur is a strategist and business developer focused on improving patient outcomes through digital technology and biotechnology.
As a co-founder of Epigene Labs based in Boston, he is mainly in charge of developing partnerships with high-profile biotechs.
He kick-started his career as a consultant at Bain & Company in the Silicon Valley and then at Accenture in New York City, before transitioning to a senior business development role at Enterome in Boston.
As a health data scientist at Epigene Labs, Julien is prototyping and testing AI-powered tools for the aggregation and analysis of health data from multiple sources. He is also highly involved in setting up the company’s technology stack.
Prior to joining Epigene Labs, Julien was a data science consultant in the Ernst & Young Advisory Experience Lab (as part of the former Bluestone Consulting team, a pioneering data science consulting firm recently acquired by Ernst & Young).